Innate Therapeutics Limited
Records under this name other than patents Innate Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Innate Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,232,010 | Compositions and methods for treatment of radiation exposure Formerly held Lapsed on the fee record Ended Mar 19, 2023 · USPTO record | Lapsed on the fee record | Ended Mar 19, 2023 | USPTO record |
| US 8,709,448 | Anti-infective agents and uses thereof Formerly held Lapsed on the fee record Ended Apr 29, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2022 | USPTO record |
| US 9,950,025 | Compositions and methods for treatment of neoplastic disease Formerly held Lapsed on the fee record Ended Apr 24, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 24, 2022 | USPTO record |
| US 8,389,479 | Compositions and methods for treatment of multiple sclerosis Formerly held Lapsed on the fee record Ended Mar 5, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 5, 2021 | USPTO record |
| US 9,415,061 | Compositions and methods for treatment of neoplastic disease Formerly held Lapsed on the fee record Ended Aug 16, 2020 · USPTO record | Lapsed on the fee record | Ended Aug 16, 2020 | USPTO record |
| US 8,110,203 | Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes Formerly held Lapsed on the fee record Ended Feb 7, 2020 · USPTO record | Lapsed on the fee record | Ended Feb 7, 2020 | USPTO record |
| US 6,043,347 | Compositions and methods for treating viral infections Term ended Term ended Oct 10, 2017 · USPTO record | Term ended | Term ended Oct 10, 2017 | USPTO record |